Dynavax Technologies (DVAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 16,998 | 23,468 | 5,171 | N/A |
| Marketable Securities | 49,254 | 5,629 | 24,239 | N/A |
| Receivables | 3,131 | 220 | N/A | N/A |
| TOTAL | $70,779 | $30,739 | $30,127 | $N/A |
| Non-Current Assets | ||||
| PPE Net | 2,465 | 828 | 1,300 | N/A |
| Other Non-Current Assets | 402 | 18 | 51 | 0 |
| TOTAL | $2,867 | $846 | $1,351 | $N/A |
| Total Assets | $73,646 | $31,585 | $31,478 | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 1,391 | 1,410 | 1,396 | 0 |
| Accrued Expenses | 4,371 | 2,989 | 2,068 | N/A |
| TOTAL | $6,762 | $4,399 | $4,214 | $N/A |
| Non-Current Liabilities | ||||
| Deferred Revenues | 1,000 | N/A | 750 | N/A |
| Other Non-Current Liabilities | 258 | 98,368 | 83,635 | 0 |
| TOTAL | $7,008 | $99,118 | $83,635 | $N/A |
| Total Liabilities | $13,770 | $103,517 | $87,849 | $N/A |
| Shareholders' Equity | ||||
| Shares Outstanding, K | 2,475 | N/A | N/A | N/A |
| Common Shares | 25 | 2 | 2 | N/A |
| Retained earnings | -95,336 | -79,365 | -62,013 | N/A |
| Other shareholders' equity | -3,887 | -5,331 | -2,783 | 0 |
| TOTAL | $59,876 | $-71,932 | $-56,371 | $N/A |
| Total Liabilities And Equity | $73,646 | $31,585 | $31,478 | $0 |